Search Within

William P Tew

  1. "Carol Aghajanian"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (36)
Groups
  1. Department of Medicine (76)
  2. GDMT, Medicine (76)
  3. Gynecologic Medicine Service (76)
  4. Gynecology Disease Management Team (76)
  5. Solid Tumor Oncology Division (76)
  6. Hematologic Malignancies, Division of (43)

More Groups

People
  1. Carol Aghajanian (76)
  2. Paul Sabbatini (50)
  3. Jason Konner (49)
  4. Martee Hensley (42)
  5. Roisin O'Cearbhaill (42)
  6. Alexia Iasonos (39)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (11)

More Years

Publications
  1. Gynecologic Oncology (27)
  2. Journal of Clinical Oncology (25)
  3. Clinical Cancer Research (6)
  4. International Journal of Gynecological Cancer (6)
  5. Cancer (2)
  6. Journal of Geriatric Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (29)
  2. American Society of Clinical Oncology (26)
  3. American Association for Cancer Research (8)
  4. Lippincott Williams & Wilkins (6)
  5. Wiley Blackwell (2)
  6. I R O G Canada, Inc (1)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Filippova, O. T.; Chi, D.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1-mutant ER+ endometrial or ovarian cancer
    Meeting Abstract

    Hyman, D.; Bonafede, M.; O'Cearbhaill, R.; Grisham, R.; Zamarin, D.; Tew, W.; Aghajanian, C.; Cadoo, K.; Friedman, C.; Savage, R. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Tew, W. P.; Sill, M. W.; Walker, J. L.; Secord, A. A.; Bonebrake, A. J.; Schilder, J. M.; Stuckey, A.; Rice, L.; Tewari, K. S.; Aghajanian, C. A.
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
    Journal Article

    LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save